ICX-PRO

N/A

Report date: 2022/11/25 18:07:22

Base Information

Drug NameICX-PRO
Drug Alias Nameallogeneic human dermal fibroblastsCyzactICX-PROICXP-007
ClassificationBiologics
Mechanisms of ActionTissue replacements
TargetsNot applicable
Therapy Area/IndicationsLeg Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntercytex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntercytex Ltd
Active IndicationsN/A
Inactive IndicationsLeg Ulcer

Other Information

ATC CodeN/A
Related LinksN/A